CHEBI:8207 - (+)-pilocarpine

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name (+)-pilocarpine
ChEBI ID CHEBI:8207
Definition The (+)-enantiomer of pilocarpine.
Stars This entity has been manually annotated by the ChEBI Team.
Supplier Information
Download Molfile XML SDF
Wikipedia License
Waiting for wikipedia content
Read full article at Wikipedia
Formula C11H16N2O2
Net Charge 0
Average Mass 208.25702
Monoisotopic Mass 208.121
InChI InChI=1S/C11H16N2O2/c1-3-10-8(6-15-11(10)14)4-9-5-12-7-13(9)2/h5,7-8,10H,3-4,6H2,1-2H3/t8-,10-/m0/s1
InChIKey QCHFTSOMWOSFHM-WPRPVWTQSA-N
SMILES CC[C@H]1[C@H](COC1=O)Cc1cncn1C
Roles Classification
Application(s): antiglaucoma drug
Any drug which can be used to prevent or alleviate glaucoma, a disease in which the optic nerve is damaged, resulting in progressive, irreversible loss of vision. It is often, though not always, associated with increased pressure of the fluid in the eye.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing (+)-pilocarpine (CHEBI:8207) has role antiglaucoma drug (CHEBI:39456)
(+)-pilocarpine (CHEBI:8207) is a pilocarpine (CHEBI:39462)
(+)-pilocarpine (CHEBI:8207) is enantiomer of (−)-pilocarpine (CHEBI:39464)
Incoming (−)-pilocarpine (CHEBI:39464) is enantiomer of (+)-pilocarpine (CHEBI:8207)
IUPAC Name
(3S,4R)-3-ethyl-4-[(1-methyl-1H-imidazol-5-yl)methyl]dihydrofuran-2(3H)-one
Synonyms Sources
(+)-pilocarpine NIST Chemistry WebBook
(3S,4R)-3-ethyldihydro-4-((1-methyl-1H-imidazol-5-yl)methyl)-2(3H)-furanone ChemIDplus
(3S-cis)-3-ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-2(3H)-furanone NIST Chemistry WebBook
Pilocarpine KEGG COMPOUND
Database Links Databases
2166 DrugCentral
C00002355 KNApSAcK
C07474 KEGG COMPOUND
D00525 KEGG DRUG
HMDB0015217 HMDB
LSM-5909 LINCS
Pilocarpine Wikipedia
View more database links
Registry Numbers Types Sources
86187 Beilstein Registry Number Beilstein
86187 Reaxys Registry Number Reaxys
92-13-7 CAS Registry Number NIST Chemistry WebBook
92-13-7 CAS Registry Number ChemIDplus
Citation Waiting for Citations Type Source
24595384 PubMed citation Europe PMC
Last Modified
22 February 2017